Why the study?
Does captopril reduce regurgitation fraction and volume in patients with aortic regurgitation?
Does captopril reduce regurgitation fraction and volume in patients with aortic regurgitation?
Captopril reduces the severity of aortic regurgitation by decreasing afterload, without significantly altering ejection fraction or systemic blood pressure.
Captopril may reduce AR regurgitant fraction without affecting EF or BP; single case leaves open need for controlled trials.
The effect of captopril mediated afterload reduction on aortic regurgitation was investigated in 10 patients. Regurgitation was quantitated by means of the regurgitation fraction and the relation of regurgitant volume to end diastolic volume. These variables were derived from gated radionuclide ventriculography. After captopril treatment the blood concentration of angiotensin I rose whereas that of angiotensin II fell significantly. The conversion of angiotensin I to II was reduced to about 50% of the control value. Whereas blood pressure and heart rate did not change significantly, the regurgitation fraction and the regurgitant volume, normalised to end diastolic volume, were significantly reduced by captopril treatment. The ejection fraction remained essentially unchanged. These findings suggest that captopril reduces aortic regurgitation by reducing afterload.
No takes yet. Share an insight, caveat, or question.
Reske et al. (1985) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: